MIMI TRAN: Open Payments
NPI 1396497905 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 77 payments from 18 companies in 2025. Trend: 2023 $2,098 · 2024 $2,137 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 41 | $266 |
| Xeris Pharmaceuticals, Inc. | 5 | $98 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Amgen Inc. | 4 | $75 |
| Lilly USA, LLC | 3 | $71 |
| Radius Health, Inc. | 2 | $65 |
| Dexcom, Inc. | 2 | $53 |
| Almatica Pharma LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
Products named: Omnipod, CRENESSITY, MOUNJARO, Tymlos, RECORLEV, Dexcom G6 Transmitter, TERIPARATIDE, EVENITY.
Industry payments across KS — which companies pay providers there.
